DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
Current Location:
> This Story

Log in or Register to rate this News Story
Forward Printable StoryPrint Comment



Cardiology Homepage

MaxQ-AI seeks $8 million public IPO listing on Nasdaq Will help FDA regulatory processes for Accipio software products

Boston Scientific to buy VENITI for $160 million Price may rise pending FDA approval of Vici Venous Stent

NIH grants $1.5 million to Magnetic Insight for development of new imaging modality Uses non-radioactive, iron oxide nanoparticle tracer

MR-conditional labeling now available for Abbotts Infinity DBS system First FDA-cleared MR-conditional directional DBS system

Boston Scientific to acquire TAVR protection system with purchase of Claret Medical Will acquire ownership of the Sentinel System to extend LVO AI-based platform beyond stroke Using $21 million from Series A funding to do so

Fewer ICDs are failing to comply with CMS NCD standards, says study Follows DOJ investigation into overuse of non-NCD-compliant ICDs

DaVita hit with $383.5 million jury verdict in dialysis death suit Three patients suffered cardiac arrest after getting GranuFlo therapy

New research finds leadless pacemakers cause fewer complications than conventional option Will they become the new standard?

Ivor Benjamin American Heart Association seats new president and officers as chairman enters 2nd of two-year term

A new tool may predict the
risk of 30-day readmissions among
TAVR patients

New tool predicts readmission among TAVR patients

by John R. Fischer , Staff Reporter
Thirty day readmission rates for TAVR patients may soon become predictable events among providers equipped with a new risk scoring tool.

That’s what researchers behind a study on the device claimed in their findings at the Society of Cardiovascular Angiography and Interventions 2018 Scientific Sessions, elaborating on its ability to score a patient’s risk of being readmitted following TAVR procedures.

Story Continues Below Advertisement

Servicing GE Nuclear Medicine equipment with OEM trained engineers

We offer full service contracts, PM contracts, rapid response, time and material,camera relocation. Nuclear medicine equipment service provider since 1975. Click or call now for more information 800 96 NUMED

"The creation of this tool and the results of the study are very assuring because it allows for better understanding of how patients should be managed peri-TAVR,” lead author Sahil Khera, a clinical and research fellow of interventional cardiology at Massachusetts General Hospital, said in a statement. “By recognizing patients at higher risk of readmission, we can guide post discharge care coordination and improve transitions of care to decrease readmission, improve quality of life, reduce healthcare costs and ultimately impact mortality rates.”

More than five million Americans are diagnosed with heart valve disease annually. Of those that undergo TAVR, nearly 15-20 percent are readmitted within 30 days, affecting positive outcomes, and together, racking up more than $40 billion in hospital costs annually.

The tool provides clinicians and medical professionals with a score to determine which patients are most at risk to be readmitted within 30 days. Probability scores are based on complex survey methods, hierarchical regression and the "rms" library.

The study examined 39,305 patients from the Nationwide Readmissions Database who underwent endovascular TAVR from January 2013 to September 2015 with researchers performing an international calibration with bootstrapping.

The final risk tool took into consideration chronic kidney disease, end stage renal disease on dialysis, anemia, chronic lung disease, chronic liver disease, atrial fibrillation, lengths of stay for more than five days, acute kidney injury, and discharge disposition.

Researchers recorded a score of 212 associated, with a readmission rate of more than 30 percent. Of the initial number of patients, 6,380 patients were readmitted within 30 days, a rate of 16.2 percent. The c-statistic of the model was 0.63.

"Use of the simple risk tool will allow the entire care team to quantify readmission risk and enhance our ability to provide personalized transitional care to hopefully mitigate this risk," said co-author Sammy Elmariah, director of interventional structural heart disease at Massachusetts General Hospital, in a statement.

The authors hope to begin using and incorporating the tools in hospital EMRs nationwide.

Cardiology Homepage

You Must Be Logged In To Post A Comment

Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Gold Service Dealer Program
Receive RFP/PS
Healthcare Providers
See all
HCP Tools
A Job
Parts Hunter +EasyPay
Get Parts
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to, Inc. Copyright ©2001-2018, Inc.